Published in J Exp Med on December 06, 2004
Hypoxia and inflammation. N Engl J Med (2011) 7.71
Ischemia and reperfusion--from mechanism to translation. Nat Med (2011) 6.64
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev (2011) 4.16
Purinergic signaling during inflammation. N Engl J Med (2012) 4.08
Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol (2006) 3.07
Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med (2012) 3.03
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology (2008) 2.99
Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal (2006) 2.98
A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood (2007) 2.70
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci U S A (2010) 2.67
A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest (2008) 2.62
The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med (2008) 2.43
HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med (2005) 2.35
Concern Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest (2012) 2.23
Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal (2012) 2.13
CD39 and CD73 in immunity and inflammation. Trends Mol Med (2013) 2.08
Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells. J Immunol (2011) 2.05
CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation. Hepatology (2013) 2.04
Adenosine: an old drug newly discovered. Anesthesiology (2009) 1.99
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest (2011) 1.82
Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther (2006) 1.82
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood (2008) 1.79
Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One (2007) 1.77
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2008) 1.75
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease. Blood (2012) 1.72
Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol (2010) 1.70
The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury. Kidney Int (2013) 1.70
A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol (2007) 1.68
Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood (2006) 1.65
Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood (2010) 1.65
Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J (2008) 1.63
Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci (2011) 1.55
Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J Immunol (2010) 1.50
Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor. J Immunol (2011) 1.48
Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J Clin Invest (2007) 1.47
HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol (2013) 1.45
Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. J Immunol (2006) 1.43
CD73 is dispensable for the regulation of inflationary CD8+ T-cells after murine cytomegalovirus infection and adenovirus immunisation. PLoS One (2014) 1.40
ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS One (2008) 1.39
Restoring auditory cortex plasticity in adult mice by restricting thalamic adenosine signaling. Science (2017) 1.39
Adenosine signaling contributes to ethanol-induced fatty liver in mice. J Clin Invest (2009) 1.38
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol (2011) 1.36
Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc Med (2008) 1.36
PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest (2008) 1.35
Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am J Physiol Gastrointest Liver Physiol (2006) 1.30
Adenosine receptor activation ameliorates type 1 diabetes. FASEB J (2007) 1.27
Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastroenterology (2011) 1.26
CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis (2009) 1.25
The resurgence of A2B adenosine receptor signaling. Biochim Biophys Acta (2010) 1.23
A role of erythrocytes in adenosine monophosphate initiation of hypometabolism in mammals. J Biol Chem (2010) 1.22
Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest (2009) 1.22
Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxid Redox Signal (2011) 1.21
Ecto-5'-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits. J Neurosci (2010) 1.20
CD73-generated adenosine promotes osteoblast differentiation. J Cell Physiol (2012) 1.18
CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J Immunol (2008) 1.18
PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Mol Pain (2011) 1.18
Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat Rev Drug Discov (2014) 1.17
Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis. J Immunol (2011) 1.16
Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J (2008) 1.16
Partial netrin-1 deficiency aggravates acute kidney injury. PLoS One (2011) 1.11
CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. FASEB J (2013) 1.10
Adenosine enhances sweet taste through A2B receptors in the taste bud. J Neurosci (2012) 1.10
New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC. Inflamm Bowel Dis (2009) 1.09
CD73 and adenosine generation in the creation of regulatory microenvironments. Clin Exp Immunol (2013) 1.08
Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol (2012) 1.07
Adenosine receptor agonists for promotion of dermal wound healing. Biochem Pharmacol (2008) 1.06
Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation. PLoS One (2012) 1.05
Juxta-articular joint-capsule mineralization in CD73 deficient mice: similarities to patients with NT5E mutations. Cell Cycle (2014) 1.05
Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation. Mol Pain (2010) 1.04
Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin Ther Targets (2009) 1.04
Adenosine signaling during acute and chronic disease states. J Mol Med (Berl) (2013) 1.02
Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virol J (2010) 1.02
Endothelial Semaphorin 7A promotes neutrophil migration during hypoxia. Proc Natl Acad Sci U S A (2012) 1.02
Ecto-5' nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ Res (2008) 1.01
Regulation of inflammation by adenosine. Front Immunol (2013) 1.01
Enzymatic properties of Staphylococcus aureus adenosine synthase (AdsA). BMC Biochem (2011) 1.00
Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukoc Biol (2008) 1.00
Extracellular nucleotide and nucleoside signaling in vascular and blood disease. Blood (2014) 0.97
Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction. Br J Pharmacol (2007) 0.97
5'-Ectonucleotidase-knockout mice lack non-REM sleep responses to sleep deprivation. Eur J Neurosci (2012) 0.97
CD73 is critical for the resolution of murine colonic inflammation. J Biomed Biotechnol (2012) 0.97
Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement. Vascul Pharmacol (2010) 0.96
Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease. J Mol Med (Berl) (2012) 0.96
Adenosine and protection from acute kidney injury. Curr Opin Nephrol Hypertens (2012) 0.96
Hypoxia signaling during intestinal ischemia and inflammation. Curr Opin Crit Care (2012) 0.95
Role of adenosine A(2B) receptors in inflammation. Adv Pharmacol (2011) 0.94
Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. J Neurosci (2013) 0.94
Loss of CD73-mediated actin polymerization promotes endometrial tumor progression. J Clin Invest (2015) 0.94
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis. J Neuroinflammation (2012) 0.94
Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med (2013) 0.94
Adenosine receptors and asthma. Handb Exp Pharmacol (2009) 0.93
Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation. J Immunol (2010) 0.93
The inflammatory tissue microenvironment in IBD. Inflamm Bowel Dis (2013) 0.93
Inhibition of hippocampal synaptic activity by ATP, hypoxia or oxygen-glucose deprivation does not require CD73. PLoS One (2012) 0.92
CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system. Proc Natl Acad Sci U S A (2012) 0.91
Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. J Biol Chem (2009) 0.91
Ecto-5'-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions. J Neurosci (2013) 0.91
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis. Clin Exp Metastasis (2013) 0.90
Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions. World J Stem Cells (2014) 0.89
Astrocytes induce blood-brain barrier properties in endothelial cells. Nature (1987) 4.70
Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol (2004) 4.28
Microvascular permeability. Physiol Rev (1999) 4.12
Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest (2002) 4.05
Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol (2001) 3.75
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med (2003) 3.71
5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest (1993) 3.02
Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood (2004) 2.80
Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev (1998) 2.46
Regulation of vascular endothelial barrier function. Am J Physiol (1994) 2.40
Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev (1994) 2.34
Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med (1998) 2.33
Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J (2002) 1.90
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest (2002) 1.80
Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol (2000) 1.77
Hypoxia enhances Ecto-5'-Nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids. Circ Res (2003) 1.76
Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost (2001) 1.61
Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res (2001) 1.61
Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci (2004) 1.53
5'-Nucleotidase from smooth muscle of small intestine and from brain. Inhibition of nucleotides. Biochemistry (1975) 1.48
Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch. Am J Physiol Cell Physiol (2002) 1.43
Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J Immunol (2000) 1.38
CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med (1995) 1.37
Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP. Am J Physiol (1998) 1.33
Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med (2002) 1.32
Control of cAMP in lung endothelial cell phenotypes. Implications for control of barrier function. Am J Physiol (1999) 1.29
CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur J Immunol (1998) 1.28
Structure and function of endothelial caveolae. Microsc Res Tech (2002) 1.27
Endothelial cells: adhesion and tight junctions. Curr Opin Cell Biol (1992) 1.27
Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res (2002) 1.23
Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport. J Neurochem (2000) 1.17
Hypoxia-induced increases in pulmonary transvascular protein escape in rats. Modulation by glucocorticoids. J Clin Invest (1988) 1.15
Ecto-5'-nucleotidase activity in T and B lymphocytes from normal subjects and patients with congenital X-linked agammaglobulinemia. J Immunol (1979) 1.07
Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res (2002) 1.01
Distribution of ecto-5'-nucleotidase on subsets of human T and B lymphocytes as detected by indirect immunofluorescence using goat antibodies. J Immunol (1987) 0.98
Ecto-5'-nucleotidase activity is not required for T cell activation through CD73. Cell Immunol (1995) 0.93
Capillaries, caveolae, calcium and cyclic nucleotides: a new look at microvascular permeability. J Mol Cell Cardiol (1998) 0.90
Capillary leak. Pathogenesis and treatment. Minerva Anestesiol (2000) 0.89
The effects of adenosine receptor agonists and antagonists on morphine state-dependent memory of passive avoidance. Neurobiol Learn Mem (2002) 0.83
Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med (2002) 7.99
Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest (2002) 4.05
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest (2004) 3.90
Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res (2002) 3.75
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med (2003) 3.71
Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation (2007) 3.65
Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem (2007) 3.28
Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol (2009) 3.24
Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation (2008) 3.13
Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med (2012) 3.03
Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol (2006) 3.03
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology (2008) 2.99
Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal (2006) 2.98
Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood (2004) 2.80
A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood (2007) 2.70
A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest (2008) 2.62
HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood (2008) 2.52
HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J (2006) 2.46
The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med (2008) 2.43
HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med (2005) 2.35
Utility of intraoperative transesophageal echocardiography for diagnosis of pulmonary embolism. Anesth Analg (2004) 2.26
ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res (2006) 2.23
Concern Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest (2012) 2.23
Cardiac output monitoring using indicator-dilution techniques: basics, limits, and perspectives. Anesth Analg (2010) 2.23
Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol (2003) 2.23
CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med (2002) 2.22
Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology (2008) 2.18
Hypoxia-induced deoxycytidine kinase contributes to epithelial proliferation in pulmonary fibrosis. Am J Respir Crit Care Med (2014) 2.13
CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation (2007) 2.09
Hypoxia and gastrointestinal disease. J Mol Med (Berl) (2007) 2.06
Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol (2007) 2.03
Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci U S A (2002) 2.01
Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol (2008) 1.93
Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol (2007) 1.90
Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J (2002) 1.90
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis (2010) 1.84
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J (2007) 1.84
Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology (2008) 1.80
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood (2008) 1.79
Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One (2007) 1.77
Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J (2008) 1.75
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease. Gastroenterology (2011) 1.73
Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol (2010) 1.70
Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A (2012) 1.70
Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol (2009) 1.68
Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res (2013) 1.68
Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol (2006) 1.68
Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J (2007) 1.67
Safety of transesophageal echocardiography. J Am Soc Echocardiogr (2010) 1.67
Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood (2010) 1.65
Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood (2006) 1.65
Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol (2009) 1.63
Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J (2008) 1.63
Retracted Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver. Proc Natl Acad Sci U S A (2013) 1.59
Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc Natl Acad Sci U S A (2004) 1.56
Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun (2008) 1.55
Detrimental effects of adenosine signaling in sickle cell disease. Nat Med (2010) 1.54
Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci U S A (2003) 1.52
Physiological roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol (2007) 1.51
Inflammatory hypoxia: role of hypoxia-inducible factor. Cell Cycle (2005) 1.50
CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med (2004) 1.49
Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor. J Immunol (2011) 1.48
Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J Clin Invest (2007) 1.47
Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology (2003) 1.45
HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol (2013) 1.45
Metabolic shifts in immunity and inflammation. J Immunol (2010) 1.45
Netrin-1 dampens pulmonary inflammation during acute lung injury. Am J Respir Crit Care Med (2010) 1.44
Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch. Am J Physiol Cell Physiol (2002) 1.43
Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis. Gut (2011) 1.39
ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS One (2008) 1.39
The feasibility of epicardial echocardiography for measuring aortic valve area by the continuity equation. Anesth Analg (2009) 1.39
Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci U S A (2010) 1.39
Acute hemodynamic collapse after induction of general anesthesia for emergent pulmonary embolectomy. Anesth Analg (2006) 1.38
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol (2011) 1.36
Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc Med (2008) 1.36
PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest (2008) 1.35
Control of IFN-alphaA by CD73: implications for mucosal inflammation. J Immunol (2008) 1.34
A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation. J Immunol (2010) 1.33
SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol (2010) 1.31
Role of extracellular adenosine in acute lung injury. Physiology (Bethesda) (2009) 1.31
Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem (2002) 1.30
Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am J Physiol Gastrointest Liver Physiol (2006) 1.30
Selective induction of mucin-3 by hypoxia in intestinal epithelia. J Cell Biochem (2006) 1.30
Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology (2007) 1.29